Cogene BioTech Ventures

Overview

Cogene BioTech Ventures is a life sciences and medical-technology venture capital firm based in Houston, Texas. The firm focuses on early-stage and expansion-stage investments across a broad spectrum of life sciences, including biopharmaceuticals and biotechnology platforms that enable better, faster, and more cost-effective therapeutic drug discovery. Other areas of investment focus include bio-nanotechnology, therapeutic medical devices, and healthcare IT/software. With approximately $50 million under management, Cogene's investments range from $200,000 to $5 million. The president and CEO of Cogene BioTech Ventures is Dr. C. Thomas Caskey, the former Senior Vice President of Research at Merck, a member of the National Academy of Sciences, and one of the nation's most respected experts on genomics. Cogene BioTech Ventures has a history of investing in companies that have achieved significant milestones. For example, the firm was an investor in Lexicon Genetics, a company that went public, and Informax, which also became a publicly traded entity. These investments highlight Cogene's commitment to supporting innovative companies in the life sciences sector. The firm's investment strategy emphasizes identifying and nurturing companies with disruptive technologies and strong management teams. By providing capital and strategic guidance, Cogene aims to accelerate the development of groundbreaking therapies and medical technologies that address unmet medical needs. This approach reflects the firm's dedication to advancing healthcare through innovation and entrepreneurship.

Investment Focus

• Innovative technologies
• Strong management teams
• Disruptive potential in life sciences

Portfolio Companies